IRCT20221129056657N2RecruitingPhase 3
The effectiveness of oral compounds derived from Organosulfur as the treatment in pediatrics with pneumonia.
Hossein Niktale - the inventor of medicine0 sites70 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 3 years to 16 years (—)
- Sex
- All
Inclusion Criteria
- •Patient age 3 to 16 years
- •The patient does not need a ventilator
- •A patient with pneumonia and hospitalized in the special care, infectious and lung department
Exclusion Criteria
- •History of allergy to allicin-L-cysteine
- •History of allergy to garlic and onion
- •Patients with a history of hypotension or gastrointestinal bleeding
- •Low blood pressure of the patient at the beginning of the study (below 120/80)
- •Immune compromised patients - under chemotherapy, organ and bone marrow transplantation, and patients with autoimmune diseases
- •The patient's inability to swallow oral medication that is not embedded in the NGtube or other delivery method.
Investigators
Similar Trials
Not yet recruiting
Phase 3
Study to compare the effectiveness and safety of two drugs in atopic dermatitis in childreCTRI/2024/02/063274IMS and SUM Hospital
Not yet recruiting
Not Applicable
To observe the efficacy of oral fluconazole versus 5% amrolfine nail lacquer in the patients of Onychomycosis.CTRI/2020/12/029904Dr Ruchir M Bhatt
Completed
Not Applicable
The effects of oral administration of bulleyaconitine A in postherpetic neuralgiaISRCTN16975505Xinhua Hospital affiliated with Shanghai Jiaotong University School of Medicine120
Recruiting
Phase 2
Evaluation of the effect of herbal anti-asthma product along with standard treatment on the intervals and severity of moderate chronic asthma attacks in children and adolescents 6 to 18 yearsmoderate persistent asthma.Moderate persistent asthmaJ45.4IRCT20090808002306N6Esfahan University of Medical Sciences40
Completed
Not Applicable
Effectiveness and safety of oral and intralesional tranexamic acid in treatment of melasmaCTRI/2021/08/035350Department of Dermatology42